Table 6. Rigor of the studies.
| Studies | Diagram | Complete list of model parameters (including natural history parameters) |
Assessment of model predictions with data (calibration details) |
Presentation of results (including sensitivity analyses)* | Discussion of model structure | Quality regarding number of items |
|---|---|---|---|---|---|---|
| Elbasha et al. 40 | Yes | Yes (appendix) | No calibration | Yes One-way SA |
No | 3/5 |
| Elbasha and Dasbach 45 | Yes | Yes (appendix) | Calibrated but method not reported | Yes PSA | Yes (appendix) |
4/5 |
| Jit et al. 46 | No | No | Yes | Yes One-way SA |
No | 2/5 |
| Kim and Goldie 47 | No | Yes (incomplete) | Yes (in another paper) | Yes One-way SA |
No | 3/5 |
| Kim 43 | No | No | Not calibrated | No sensitivity analyses | No | 0/5 |
| Taira et al. 42 | Yes | No | Calibrated but method not reported | Yes One-way SA |
No | 2/5 |
| Zechmeister et al. 41 | Yes | Yes | Calibrated but method not reported | Yes | No | 3/5 |
| Olsen and Jepsen 48 | Yes (online appendix) | Yes | Calibrated but method not reported | One-way SA but results not shown | No | 2/5 |
| Chesson et al. 49 | Yes | Yes (appendix) | No calibration Based on published literatures | Yes | No | 3/5 |
*
Sensitivity analyses are conducted for vaccine parameters, cost and utilities. Natural history parameters such as the probability of transmission are not included in sensitivity analyses. Cross-protection has been included in some sensitivity analyses. SA, sensitivity analyses; PSA, probabilistic sensitivity analyses.